Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 02:10PM GMT
Release Date Price: $123.96 (+6.34%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Awesome. I think that's it, right? We're ready to go.

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

Let's go, Luke.

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

I think so. Yes. So pleased here to introduce Jeff Elliot of Exact Sciences. Been covering it for -- or covered it a while in my last -- in my previous life, and known Jeff for a very long time, fantastic guy. No death defying events here. You have to get the side question on that one in the breakout.

Questions & Answers

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

But I guess we could just dive right into it. And so as I think about how active you guys have been and when you acquired Thrive. And there's a lot of stuff that you've done from Cologuard that you can take to the -- a lot of these newly acquired businesses, a lot of the learnings. And as you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot